Hybrox 75 mg (Capsule (Sustained Release))
Medicine Details
| Category | Details |
|---|---|
| Generic | Ambroxol hydrochloride |
| Company | Kemiko pharmaceuticals ltd |
| Also available as |
Title
- Hybrox Cough Expectorant Syrup
Categories
- Medicine
- Healthcare
- Pharmaceutical
Description
Hybrox is indicated for productive cough, acute and chronic inflammatory disorders of upper and lower respiratory tracts, inflammatory disease of rhinopharyngeal tract, asthmatic bronchitis, bronchiectasis, chronic pneumonia, etc. It has pharmacological effects that improve sputum rheology, hydrate mechanism, stimulate surfactant production, reduce bronchial hyperactivity, and possess anti-inflammatory properties. The average daily dosage varies by age group. It is contraindicated in known hypersensitivity to Ambroxol or Bromhexine. Gastrointestinal side effects and allergic responses may occur. Safety during pregnancy and lactation has not been fully established. Precautions need to be taken for patients with specific health conditions.
Indications
- Productive cough
- Acute and chronic inflammatory disorders of upper and lower respiratory tracts
- Inflammatory disease of rhinopharyngeal tract
- Asthmatic bronchitis
- Bronchiectasis
- Chronic pneumonia
Pharmacology
- Greater bronchosecretolytic effect
- Improves sputum rheology
- Hydrating mechanism
- Stimulates surfactant production
- Reduces bronchial hyperactivity
- Anti-inflammatory
Dosage administration
- Pediatric Drops
- Syrup
- Sustained release capsule
Interaction
- Avoid simultaneous intake with antitussives like Codeine
Contraindications
- Known hypersensitivity to Ambroxol or Bromhexine
Side effects
- Gastrointestinal side effects
- Allergic responses
Pregnancy lactation
- Teratogenic and fetal toxicity studies
- Advised not to use in the 1st trimester
- Safety during lactation not fully established
Precautions warnings
- Cautious use for patients with gastric and duodenal ulceration
- Cautious use for patients with convulsive disorders
- Cautious use for patients with hepatic and renal insufficiency
Therapeutic class
Cough expectorants & mucolytics
Storage conditions
- Protect from direct light exposure
- Store in a dry place at a temperature not exceeding 30°C
- Keep out of the reach of children